Abstract
Purpose of review
Transgender individuals display incongruence between their assigned birth sex and their current gender identity, and may identify as male, female or elsewhere on the gender spectrum. Gender nonconformity describes an individual whose gender identity, role, or expression are not typical for individuals in a given assigned sex category. This update highlights recent literature pertaining to the psychosocial and medical care of transgender and gender nonconforming (TGN) adolescents with applications for the general practitioner.
Recent findings
The psychological risks and outcomes of TGN adolescents are being more widely recognized. Moreover, there is increasing evidence that social and medical gender transition reduces gender dysphoria, defined as distress that accompanies the incongruence between one’s birth sex and identified gender. Unfortunately, lack of education about TGN adolescents in medical training persists.
Summary
Recent literature highlights increased health risks in TGN adolescents and improved outcomes following gender dysphoria treatment. It is important for clinicians to become familiar with the range of treatment options and referral resources available to TGN adolescents in order to provide optimal and welcoming care to all adolescents.
Keywords: adolescent, gender identity, gender nonconforming, transgender
Introduction
Primary care providers may be the first medical professionals to whom a transgender or gender non-conforming (TGN) adolescent presents. This first impression may set the stage for a given adolescent’s views of the medical field in general. Moreover, clinicians who care for adolescents have a responsibility to provide medical care that is non-judgmental and comprehensive (1). Research has increasingly been conducted with regards to the psychosocial needs of TGN adolescents following the establishment of treatment guidelines for transgender individuals by The Endocrine Society (2) and the World Professional Association for Transgender Health (WPATH) (3). Herein, the psychosocial and medical care of TGN adolescents is reviewed in order to provide guidance to general practitioners.
Gender identity
It is important to become familiar with the terminology used in medical and TGN communities (Table 1 (3,4)). Transgender individuals display incongruence between their assigned birth sex and their current gender identity, defined as their internal identification as male, female or elsewhere on the gender spectrum (3). Gender nonconformity describes an individual whose gender identity, role, or expression are not typical for individuals in a given assigned sex category. Gender dysphoria is defined as distress that may accompany the incongruence between one’s experienced or expressed gender and one’s assigned sex. Gender identity and expression are not the same as sexual orientation (5). When discussing gender identity with patients, providers should inquire if patients have a preferred pronoun.
Table 1.
Term | Definition |
---|---|
Cross-sex hormones | Use of feminizing hormones in an individual assigned male at birth, or masculinizing hormones in an individual assigned female at birth. |
Female-to-Male (FTM) | Individuals assigned female at birth who identify on the masculine spectrum and may undergo gender affirming medical treatments to masculinize their body |
Gender dysphoria | An individual’s affective/cognitive discontent with the assigned sex. Refers to the distress that may accompany the incongruence between one’s experienced or expressed gender and one’s assigned sex. |
Gender identity | An individual’s internal identification as male, female or elsewhere on the gender spectrum |
Gender non-conforming/gender atypical | An individual whose gender identity, role, or expressionis not typical of individuals with the same assigned sex in a given society and historical era |
Genderqueer | A term which may be used by individuals whose gender identity and/or role does not conform to a binary understanding of gender as limited to the categories of male or female |
Gender role | Personality, appearance, and behavior traits that society designates as masculine or feminine |
Male-to-Female (MTF) | Individuals assigned male at birth who identify on the feminine spectrum and may undergo gender affirming medical treatments to feminize their body |
Sex | Biological indicators of male and female, such as sex chromosomes, gonads, sex hormones, and internal/external genitalia. |
Gender affirmation surgery (Sex reassignment surgery) | Surgery to change primary and/or secondary sex characteristics to affirm a person’s gender identity. |
Transgender | Adjective to describe a diverse group of individuals who cross defined categories of gender |
Transsexual | Term to describe individuals who seek to change or have changed their primary and/or secondary sex characteristics through medical interventions (hormones and/or surgery) with a permanent change in gender role |
Transition | Period of time when individuals change from the gender role associated with their sex assigned at birth to a different gender role. The nature and duration of transition are variable and individualized. |
Gender identity typically develops in early childhood for both gender conforming and non-conforming youth, but can be a dynamic and evolving characteristic from childhood into adolescence and adulthood. For example, a pre-pubertal child who is gender nonconforming or who has apparent gender dysphoria may or may not identify as transgender later in life. The gender identity affirmed during puberty appears to predict the gender identity that will persist into adulthood (6). Estimates for the likelihood of gender dysphoria persisting from childhood into adulthood range from 2–27% depending on the study (6). Youth with persistent TGN identity into adulthood have greater gender dysphoria and are more likely to have experienced social transition, such as using a different name or changing their style of clothing to that which is stereotypically associated with another gender at some point during childhood (6).
Primary care considerations for the TGN adolescent
As a primary care provider, it is important to use verbal and body language that demonstrates acceptance and openness to all patients, but especially to those who are TGN. The practitioner should inquire how the adolescent identifies their gender, and may open the conversation by using open-ended questions such as: “Many people struggle with gender. Is this an issue for you?” (7).
When performing a comprehensive medical and social history with a TGN adolescent there are particular issues that should be specifically addressed:
Home
Gender nonconforming youth may experience conflict with family members who do not understand or accept their gender identification. It is important to assess for parental/family awareness of and support for the adolescent’s current gender identification. Parental support is positively associated with condom use among transgender female youth (8) and with higher life satisfaction and fewer depressive symptoms among transgender adolescents (9,10). In situations where the TGN adolescent is not supported by family, the adolescent may be at risk for homelessness (10,11). It is important to ask TGN adolescents if they are concerned about homelessness following disclosure of their gender identity to their family.
School
School is an important social environment for adolescents. A survey of New Zealand high school students found that students who self-identified as transgender were at increased risk of being bullied and in physical fights at school with more than half of them being afraid that someone would hurt or bother them at school (12). Similarly, a nationwide internet survey in the United States (US) found that TGN youth were at higher risk for bullying or harassment compared to their non-TGN peers (13). Adolescents who are gender nonconforming in their expression and behavior at early ages are at increased risk of bullying and verbal and physical abuse by adulthood (14). Moreover, the greater the gender non-conformity, the greater the victimization experienced at school (15).
An ally at school, such as a counselor or teacher, should be identified. Changing clothes for physical education classes or using the bathroom can be stressful or even dangerous for TGN adolescents (5). Bullying in a bathroom may occur as there is no adult supervision, which may result in TGN youth refraining from using the bathroom at school out of fear (5). A patient may not know if there are anti-harassment policies at their school, and this should be investigated.
Substance Use
Although all adolescents should be asked about substance use, TGN youth may be at higher risk for us than non-TGN youth. One online survey found that TGN youth of any gender were more likely than non-TGN boys to have used alcohol, tobacco, marijuana, and other illicit substances in the past twelve months (13). Moreover, TGN youth who are bullied are at higher risk of substance use (13).
Sexual Health
As with all adolescents, it is necessary to ask and counsel on matters related to sexual and reproductive health. As TGN patients may have significant dysphoria related to their genitals, it may be prudent to ask if they have preferred terms for their genitalia (7). Female to male (FTM) patients may have discomfort around pelvic exams or desire continuous oral contraceptives to suppress menses (16).
For those who are engaging in penile-vaginal sex, it is important to discuss contraception. Protection against sexually transmitted infections, including the use of condoms and/or dental dams, should be discussed with patients engaging in any type of sexual behavior. If the patient is on cross-sex hormones, it is important to remind them that while a side effect may be infertility, such therapies should not be relied upon for contraception (7). For FTM patients who are on testosterone, they should be aware that testosterone is contraindicated in pregnancy and may have adverse effects on a developing fetus. Exogenous testosterone may increase sexual desire and clitoral pain (17). Male to female (MTF) patients on estrogen therapy may experience decreased sexual desire as a side effect of decreased testosterone concentrations (17,18). Decreased libido may also be a side effect of puberty suppressing medications (18).
Mental Health
All adolescents should be evaluated for mental health disorders including depression, anxiety, and suicidality. The TGN adolescent may benefit from referral to mental health providers for a variety of reasons (3). Family counseling and psychotherapy may be necessary to address gender dysphoria, co-morbid mood disorders, and the effect of these conditions on the rest of the family. Assessment by a mental health professional is suggested prior to initiation of puberty blockers or cross-sex hormones to formally diagnose gender dysphoria and to support the TGN adolescent through the transition process (2,3). Additionally, mental health providers can act as liaisons for patients and families with medical and educational systems.
Recent research has focused on the mental health needs and risks of patients with gender dysphoria. Compared to matched non-TGN peers at a single community health center, TGN adolescents and young adults were at two to three times greater risk of depression, anxiety, and suicidal ideation (19). A survey of New Zealand high school students found that one in five students who identified as transgender had attempted suicide in the prior twelve months (12). These findings highlight the importance of assessing mood and suicidal ideation during visits with these patients. Providers should also ask about the timing of gender identity development, as gender nonconformity prior to age eleven is associated with an elevated risk of depressive symptoms (14).
Not surprisingly, following social and medical gender transition, there is reduced gender dysphoria and improved psychological functioning (20). This emphasizes the need to identify TGN adolescents early in order to refer them to appropriate counseling and specialists if they choose to undergo gender-affirmative treatments.
Medical Management
Both The Endocrine Society and WPATH offer recommendations on the medical management of transgender adolescents (2,3). Medication regimens with dosing and administration route are summarized elsewhere (21). Although the medications used are commonly prescribed for other purposes, they are used off-label for treatment of gender dysphoria. Medical professionals have an ethical responsibility to help adolescents appropriately weigh the pros and cons of cross-sex hormonal therapies. (22). Clinicians may not feel comfortable managing such therapies themselves, but should be aware of potential side effects of hormonal interventions and any specific monitoring requirements. Providers must also be aware of specialists to whom TGN adolescents can be referred for this important medical management.
Early Puberty
If a patient presents with gender dysphoria in early puberty (sexual maturity rating 2), pubertal suppression with a GnRH agonist, such as leuprolide or histrelin, can be considered. This allows for further exploration of gender identity prior to the initiation of cross-sex hormones, which may have irreversible effects. Recommendations for monitoring TGN adolescents on pubertal suppressive medications can be found in Rosenthal’s “Approach to the patient: transgender youth: endocrine considerations” (21).
Late puberty
If the adolescent presents with gender dysphoria later in puberty (sexual maturity rating 4/5), GnRH agonists can be used to suppress the hypothalamic-pituitary-gonadal axis to potentially enable the use of lower doses of cross-sex hormones (21). According to the Endocrine Society guidelines, cross-sex hormones can be initiated around age 16 years (2). However, some institutions begin cross-sex hormones at age 14 years with a slow increase of hormones over 2–3 years (21). In addition to GnRH analogues, spironolactone can be used in MTF patients to reduce the effect of testosterone on its receptor.
Cross-sex hormones may be introduced in order to achieve feminizing or virilizing secondary sex characteristics so that a TGN patient’s physical appearance will be more aligned with their gender identity. For MTF patients, 17-β-estradiol has numerous delivery routes. Side effects may include impaired insulin sensitivity and hyperprolactinemia (2). There is additional risk of thromboembolic events (18). For FTM patients, testosterone is most commonly given intramuscularly. Side effects include cystic acne, polycythemia, hypertension, adverse changes in lipid profile, possible insulin insensitivity, and risk of impaired fertility (2). Recommendations for monitoring TGN patients who are on cross-sex hormone therapies can be found in Rosenthal’s “Approach to the patient: transgender youth: endocrine considerations” (21).
There is some data with regards to outcomes associated with cross-sex hormone treatment. A case report described the first patient treated with pubertal blockers followed by cross-sex hormone treatment in an Amsterdam clinic 22 years after initial treatment (23). This FTM individual received 4.9 years of a GnRH agonist followed by testosterone injections every 2–3 weeks. At age 35, he was found to have bone mineral density above the 50th percentile for females, normal serum values for lipids, hemoglobin A1C, glucose and insulin, and was living happily as a man without regrets regarding his gender transition. A more recent study of the short-term effects of cross-sex hormone therapy in FTM patients found that there were no deaths or severe adverse effects (17). Of 53 FTM patients, two had erythrocytosis and two had transient elevation of liver enzymes. Of the 53 MTF patients, three had transient liver enzyme increase. It is important to emphasize that body image dysphoria remits following cross-sex hormonal therapy and gender affirming surgery, while harassment decreases and patient quality of life and satisfaction with life improves (20).
Surgical intervention
Gender affirming surgery (previously referred to as sex reassignment surgery) is an irreversible intervention and is considered the final phase of medical gender transition (15). The timing of the procedure remains controversial. Patients must have the cognitive ability to understand the risks and benefits of the procedure. They must also have adequate genital tissue for reconstruction (16). WPATH guidelines state that the patient should be of legal age for medical procedure consent and have lived continuously for 12 months in their identified gender (3). The Endocrine Society guidelines advise that surgical procedures should be done when a person is at least 18 years old (2). For FTM patients, one year of testosterone treatment is recommended prior to surgery (3). FTM patients may desire hysterectomy due to dysphoria associated with menses. If this procedure is performed, patients and primary medical providers must be told if the cervix remains, as pap smears for cervical cancer screening would still be indicated. Cross-sex hormone treatment continues after gender affirming surgery for continued feminization or masculinization and maintenance of bone health. Some transgender individuals decide to forgo gender affirming surgery either for personal or financial reasons, but may decide to continue on life-long cross-sex hormone treatment
Barriers to Care
Several barriers to care exist for TGN patients. Lack of medical provider knowledge can make patients feel unwelcome and can hinder appropriate referral for mental health or hormonal interventions. A survey of medical schools in 2009–2010 found that the median number of hours of LGBT content was five hours with one-third of schools reporting no LGBT curriculum during the clinical years (24). Additionally, in a medical school class in Philadelphia, 74% of respondents had 2 hours or less of transgender health topics in medical school (25). However, the Philadelphia students who received an additional lecture on transgender health during their clerkship years had improved knowledge, attitudes and skills compared to students who had not received the lecture. Thus, the addition of even one medical school lecture may improve provider competency in caring for TGN patients.
Insurance coverage represents an additional barrier to care for TGN patients. In the US, cross-hormone or pubertal suppressive therapies are prescribed off-label and may be denied by insurance companies. Gender affirming surgery is infrequently covered by insurance and is a cost-prohibitive treatment for some. However, progress is being made in this arena. At the time of this publication, three US states have Medicaid programs that cover medical services for the treatment of gender dysphoria: California, Vermont, and Massachusetts (26).
In addition to cost, many TGN individuals have difficult or even discriminatory experiences with the medical system. A survey of transgender adolescents and adults from Ontario, Canada found that more than half of respondents reported a negative experience during care in an emergency department, and at least 1 in 5 had avoided the emergency room due to fears that their gender identity may negatively affect their care (27). The National Transgender Discrimination Survey, a national retrospective survey study of TGN adults in the US, found that half of respondents postponed seeking medical care when they were sick due to discrimination or financial concerns (28).
Conclusion
Primary care providers are optimally positioned to welcome TGN adolescent patients to medical care and to create a medical home (28). This is especially important for a patient population that has historically been marginalized. While primary care clinicians may not feel equipped to prescribe hormonal therapies for this population, screening TGN adolescents, creating a safe environment for them in the medical system, and appropriately referring them to mental health and medical care is exceedingly important.
Key Points.
Primary care providers are optimally positioned to welcome TGN adolescent patients to medical care and to create a medical home.
TGN youth are at higher risk for bullying or harassment, substance use, and depression than their non-TGN peers.
There are several published guidelines to help guide medical and surgical transition.
Following social and medical gender transition, there is reduced gender dysphoria and improved psychological functioning.
Acknowledgements
None
Financial Support and Sponsorship: Drs. Guss and Katz-Wise are supported by a grant from the Maternal and Child Health Bureau, Health Resources and Services Administration (Leadership Education in Adolescent Health project T71-MC00009). Dr. Katz-Wise is additionally supported by a grant from the National Institute of Child Health and Development (NIH R01 HD066963) and was supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NIH K99HD082340). Dr. Shumer is supported by NICHD grant 1T32HD075727-01.
Footnotes
None of the authors have financial conflicts of interest to disclose.
Bibliography
- 1.J Adolesc Health [Internet] 4. Vol. 52. Society for Adolescent Health and Medicine; 2013. Apr, [cited 2014 Oct 23]. Recommendations for promoting the health and well-being of lesbian, gay, bisexual, and transgender adolescents: a position paper of the Society for Adolescent Health and Medicine; pp. 506–510. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23521897. [DOI] [PubMed] [Google Scholar]
- 2.Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ, Spack NP, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. [cited 2014 Dec 30];J Clin Endocrinol Metab [Internet] 2009 Sep;94(9):3132–3154. doi: 10.1210/jc.2009-0345. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19509099. [DOI] [PubMed] [Google Scholar]
- 3.Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, Decuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S, Adler RK, Brown GR, Devor AH, Ehrbar R, Ettner R, Eyler RG E. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. [cited 2014 Dec 30];Int J Transgenderism [Internet] 2012 13(4):165–232. Available from: http://hollis.harvard.edu/primo_library/libweb/action/display.do?frbrVersion=5&tabs=detailsTab&ct=display&fn=search&doc=TN_tayfranc10.1080/15532739.2011.700873&indx=1&recIds=TN_tayfranc10.1080/15532739.2011.700873&recIdxs=0&elementId=0&renderMode=poppedOut&displayMode=full&frbrVersion=5&dscnt=0&vl(1UI0)=contains&onCampus=false&query=any,contains,Standards+of+care+for+the+health+of+transsexual++transgender++and+gender-nonconforming+people&scp.scps=primo_central_multiple_fe&tab=articles&ds. [Google Scholar]
- 4.Force APAAPAD-5 T. Diagnostic and statistical manual of mental disorders?: DSM-5. Arlington, VA: American Psychiatric Association; 2013. [Google Scholar]
- 5. Johnson CW, Singh Aa, Gonzalez M. “It’s complicated”: collective memories of transgender, queer, and questioning youth in high school. [cited 2014 Dec 12];J Homosex [Internet] 2014 Jan;61(3):419–434. doi: 10.1080/00918369.2013.842436. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24438341. * This qualitative study offers insights into the experienes of transgender and gender nonconforming youth.
- 6.Steensma TD, McGuire JK, Kreukels BPC, Beekman AJ, Cohen-Kettenis PT. J Am Acad Child Adolesc Psychiatry [Internet] 6. Vol. 52. Elsevier Inc; 2013. Jun, [cited 2014 Dec 10]. Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study; pp. 582–590. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23702447. [DOI] [PubMed] [Google Scholar]
- 7.Vries A De, Cohen-kettenis P, Waal HD De, Holman CW, Goldberg J. Caring for Transgender Adolescents in BC?: Suggested Guidelines. 2006 [Google Scholar]
- 8.Wilson EC, Iverson E, Garofalo R, Belzer M. Parental support and condom use among transgender female youth. [cited 2014 Dec 29];J Assoc Nurses AIDS Care [Internet] 2012 23(4):306–317. doi: 10.1016/j.jana.2011.09.001. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3288276&tool=pmcentrez&rendertype=abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Simons L, Schrager SM, Clark LF, Belzer M, Olson J. J Adolesc Heal [Internet] 6. Vol. 53. Elsevier Ltd; 2013. Dec, [cited 2014 Oct 13]. Parental support and mental health among transgender adolescents; pp. 791–793. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24012067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Services DY. Impacts of Strong Parental Support for Trans Youth A report prepared for Children’s Aid Society of Toronto and Delisle Youth Services. 2012:1–5. [Google Scholar]
- 11.Mayer KH, Garofalo R, Makadon HJ. Am J Public Health [Internet] 6. Vol. 104. American Public Health Association Inc; 2014. Jun, [cited 2014 Sep 9]. Promoting the successful development of sexual and gender minority youths; pp. 976–981. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24825194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Clark TC, Lucassen MFG, Bullen P, Denny SJ, Fleming TM, Robinson EM, et al. J Adolesc Heal [Internet] 1. Vol. 55. Elsevier Inc; 2014. Jul, [cited 2014 Sep 16]. The Health and Well-Being of Transgender High School Students: Results From the New Zealand Adolescent Health Survey (Youth’12) pp. 93–99. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L52957884\nhttp://dx.doi.org/10.1016/j.jadohealth.2013.11.008\nhttp://gerion.greendata.es:443/sfxlcl3?sid=EMBASE&sid=EMBASE&issn=1054139X&id=doi:10.1016/j.jadohealth.2013.11.008&atitle=The+Health+and+Well-Being+of+Transgender+High+School+Students:+Results+From+the+New+Zealand+Adolescent+Health+Survey+(Youth’12)&stitle=J.+Adolesc.+Health&title=Journal+of+Adolescent+Health&volume=&issue=&spage=&epage=&aulast=Clark&aufirst=Ter. [DOI] [PubMed] [Google Scholar]
- 13.Reisner SL, Greytak Ea, Parsons JT, Ybarra ML. Gender Minority Social Stress in Adolescence: Disparities in Adolescent Bullying and Substance Use by Gender Identity. [cited 2014 Oct 13];J Sex Res [Internet] 2014 Apr 17;:1–14. doi: 10.1080/00224499.2014.886321. (May): Available from: http://www.ncbi.nlm.nih.gov/pubmed/24742006. [DOI] [PMC free article] [PubMed]
- 14.Roberts AL, Rosario M, Slopen N, Calzo JP, Austin SB. Childhood gender nonconformity, bullying victimization, and depressive symptoms across adolescence and early adulthood: an 11-year longitudinal study. [cited 2014 Dec 24];J Am Acad Child Adolesc Psychiatry [Internet] 2013 Feb;52(2):143–152. doi: 10.1016/j.jaac.2012.11.006. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3635805&tool=pmcentrez&rendertype=abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Toomey RB, Ryan C, Diaz RM, Card Na, Russell ST. Gender-nonconforming lesbian, gay, bisexual, and transgender youth: School victimization and young adult psychosocial adjustment. [cited 2014 Dec 24];Psychol Sex Orientat Gend Divers [Internet] 2013 1(S):71–80. doi: 10.1037/a0020705. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/2329-0382.1.S.71. [DOI] [PubMed] [Google Scholar]
- 16. Unger Ca. Gynecologic care for transgender youth. [cited 2014 Oct 13];Curr Opin Obstet Gynecol [Internet] 2014 Oct;26(5):347–354. doi: 10.1097/GCO.0000000000000103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25127077. * This review offers helpful information regarding the gynecological care and surgical interventions for transgender adolescents.
- 17.Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher A, Toye K, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. [cited 2014 Dec 30];J Sex Med [Internet] 2014 Aug;11(8):1999–2011. doi: 10.1111/jsm.12571. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24828032. [DOI] [PubMed] [Google Scholar]
- 18.Smith KP, Madison CM, Milne NM. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults. [cited 2014 Dec 29];Pharmacotherapy [Internet] 2014 Dec;34(12):1282–1297. doi: 10.1002/phar.1487. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25220381. [DOI] [PubMed] [Google Scholar]
- 19. Reisner SL, Vetters R, Leclerc M, Zaslow S, Wolfrum S, Shumer D, et al. J Adolesc Heal [Internet] Elsevier; 2015. Jan, [cited 2015 Jan 9]. Mental Health of Transgender Youth in Care at an Adolescent Urban Community Health Center: A Matched Retrospective Cohort Study. Available from: http://www.jahonline.org/article/S1054139X14006934/fulltext. * This recent matched retrospective cohort study demonstrates the disparities in mental health outcomes of transgender adolescents compared to their non-transgender peers.
- 20. De Vries ALC, McGuire JK, Steensma TD, Wagenaar ECF, Doreleijers TaH, Cohen-Kettenis PT. Young adult psychological outcome after puberty suppression and gender reassignment. [cited 2014 Dec 4];Pediatrics [Internet] 2014 Oct;134(4):696–704. doi: 10.1542/peds.2013-2958. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25201798. ** This is an important study offering evidence regarding the benefits of cross-sex hormones and surgery for adolescents with gender dysphoria.
- 21. Rosenthal SM. Approach to the patient: transgender youth: endocrine considerations. [cited 2014 Dec 7];J Clin Endocrinol Metab [Internet] 2014 Dec;99(12):4379–4389. doi: 10.1210/jc.2014-1919. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25140398. ** This highlights gender identity development, epidemiology, and clinical practice guidelines regarding transgender and gender nonconforming adolescents. It clearly outlines recommended screening and treatment monitoring guidelines.
- 22.Abel BS. Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis. [cited 2014 Dec 24];Hastings Cent Rep [Internet] 2014 Sep;44(Suppl 4):S23–S27. doi: 10.1002/hast.366. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25231782. [DOI] [PubMed] [Google Scholar]
- 23.Cohen-Kettenis PT, Schagen SEE, Steensma TD, de Vries ALC, Delemarre-van de Waal HA. Arch Sex Behav [Internet] 4. Vol. 40. Springer; 2011. Aug 1, [cited 2014 Dec 24]. Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up; pp. 843–847. Available from: /pmc/articles/PMC3114100/?report=abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Obedin-maliver J, Goldsmith ES, Stewart L, White W, Tran E, Brenman S, et al. Lesbian, Gay, Bisexual, and Transgender–Related Content in Undergraduate Medical Education. 2014;306(9):971–977. doi: 10.1001/jama.2011.1255. [DOI] [PubMed] [Google Scholar]
- 25.Dowshen N, Nguyen GT, Gilbert K, Feiler A, Margo KL. Improving transgender health education for future doctors. [cited 2014 Dec 24];Am J Public Health [Internet] 2014 Jul;104(7):e5–e6. doi: 10.2105/AJPH.2014.301978. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24832417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fox JC. State to cover gender reassignment surgery and hormone treatment for transgender patients [Internet] [cited 2014 Dec 30];The Boston Globe. 2014 Available from: http://www.bostonglobe.com/metro/2014/06/20/state-cover-gender-reassignment-surgery-and-hormone-treatment-for-transgender-patients/a9OPrvqdUPmRoiAQugVwEO/story.html. [Google Scholar]
- 27.Bauer GR, Scheim AI, Deutsch MB, Massarella C. Reported emergency department avoidance, use, and experiences of transgender persons in Ontario, Canada: results from a respondent-driven sampling survey. [cited 2014 Dec 15];Ann Emerg Med [Internet] 2014 Jun;63(6):713–720.e1. doi: 10.1016/j.annemergmed.2013.09.027. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24184160. [DOI] [PubMed] [Google Scholar]
- 28.Cruz TM. Assessing access to care for transgender and gender nonconforming people: a consideration of diversity in combating discrimination. [cited 2014 Dec 19];Soc Sci Med [Internet] 2014 Jun;110:65–73. doi: 10.1016/j.socscimed.2014.03.032. Available from: http://www.sciencedirect.com/science/article/pii/S0277953614002111. [DOI] [PubMed] [Google Scholar]